An audit of compliance with the updated post-polypectomy and post-colorectal cancer resection surveillance guidelines at a District General Hospital (DGH)

Background: It is important we identify cases of premalignant polyps and stratify patients according to future colorectal cancer (CRC) risk to prevent CRC development. In 2020, the British Society of Gastroenterology (BSG) published guidelines to tailor post-polypectomy and post-CRC resection surveillance. The objective of our audit was to determine whether our department was adhering to these guidelines. Method(s): We performed a retrospective audit of patients who had a colonoscopy at a DGH from February to June 2021. We reviewed case notes for indication, findings, and compliance to BSG's guidelines. Result(s): A total of 578 cases were reviewed. The median age was 61 years old. Most of the referrals were via the 2-week-wait pathway. 285 had normal findings on colonoscopy, 28 had CRC, 22 had polyps meeting high risk findings, and 12 had large non-pedunculated colorectal polyps. Our unit was 93.6% (547/578) compliant with the guidelines. 6.4% (31/578) were not compliant. Of those, 18 were scheduled for a surveillance colonoscopy when the polyps did not meet the criteria, 6 colonoscopies were not booked within the appropriate timeframe, 2 did not have their 6-month site check, and 1 had a surveillance colonoscopy despite a normal index colonoscopy. Conclusion(s): Our unit is highly compliant with BSG's guidelines. COVID-19 may have influenced the timing of colonoscopies, which could have impacted our compliance. Furthermore, there is little data on how our DGH compares to national data. We have placed the updated guidelines throughout the department to enhance awareness across the wider team. Copyright © 2022

s of the BSG Annual Meeting

The proceedings contain 386 papers. The topics discussed include: improved patient selection for peg insertion in England between 2007-2019;a multi-centre study of infliximab treatment for corticosteroid-refractory checkpoint inhibitor induced enterocolitis;risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications: reassuring insights from prepare-IBD;percutaneous liver biopsy to confirm advanced metastatic cancer: a step too far?;e-health versus standard care in inflammatory bowel disease management: a systematic review and meta-analysis;results of rapid hepatitis c treatment scale-up for people who inject Drugsin Tayside, Scotland;computer aided characterisation of colorectal polyps using artificial intelligence;and ambulatory care management of 70 patients with acute severe UC in comparison to 700 inpatients.